China Sanjiang Fine Chemicals nearly doubles net profit in H1 2025

China Sanjiang Fine Chemicals Company Limited reported a robust financial performance for the six months ended June 30, 2025, with net profit attributable to equity holders increasing by approximately 95.5% to RMB301.1m, up from RMB154.1m in the same period of 2024. Despite a slight decrease in revenue to RMB9,105,675 thousand from RMB9,239,833 thousand, the group's gross profit margin improved by 0.9% to 5.1%. This was primarily driven by favorable market dynamics for Ethylene Glycol (EG) and the group's agile operational strategies, including dynamic adjustments to procurement and production mixes. Earnings per share rose to RMB26.01 fens from RMB13.30 fens.

The company's operational flexibility, benefiting from integrated EO/EG and Naphtha/Ethane/Propane-to-Ethylene/Propylene facilities, allowed for optimized raw material costs and product portfolio adjustments. Key products like EG and Butadiene sustained strong performance, while EO and Surfactants saw steady demand. The group also recorded approximately RMB81.3m in profit from positive price movements in silver used in catalysts. However, the board did not recommend an interim dividend to maintain financial flexibility amid potential economic turbulence.

Additionally, on September 11, 2025, China Sanjiang Fine Chemicals Company Limited repurchased 1m of its ordinary shares on the Exchange at prices between HK$1.72 and HK$1.77 per share, totaling an aggregate price paid of HK$1,745,500. This repurchase represents 0.08% of the existing issued shares and occurred under a mandate granted on May 30, 2025.